FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1749-1754 December 5, 1996 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Currently, there are 50,000 to 75,000 girls and women with Turner's syndrome in the United States alone. Turner's syndrome, first described in 1938,¹ is the most common sex-chromosome abnormality in females, affecting an estimated 3 percent of all females conceived. However, the frequency among live-born female infants is only 1 in 1500 to 1 in 2500, and as many as 15 percent of spontaneous miscarriages have a 45,X karyotype. It is estimated that only 1 in 100 embryos with a 45,X karyotype survive to term.² Molecular studies have shown that the maternal X is retained in two thirds of patients . . . [Full Text of this Article]

Prenatal Management

Care of Infants and Children

Care of Adults

Fertility and Family Planning

Psychological and Educational Issues

Source Information

From the Division of Pediatric Endocrinology, Albert Einstein College of Medicine–Montefiore Medical Center, 111 E. 210th St., Bronx, NY 10467, where reprint requests should be addressed to Dr. Saenger.

References

Related Letters:

Turner's Syndrome
Gargan T. J., Peerzada J. M., Rozycki A. A., Nordgren R. E., Taback S. P., Deal C., Van Vliet G., Saenger P.
Extract | Full Text  
N Engl J Med 1997; 336:1526-1528, May 22, 1997. Correspondence

This article has been cited by other articles:

• Hardin, D. S., Kemp, S. F., Allen, D. B. (2007). Twenty Years of Recombinant Human Growth Hormone in Children: Relevance to Pediatric Care Providers. CLIN PEDIATR 46: 279-286 [Abstract]  
• Papp, C., Beke, A., Mezei, G., Szigeti, Z., Ban, Z., Papp, Z. (2006). Prenatal Diagnosis of Turner Syndrome: Report on 69 Cases. J Ultrasound Med 25: 711-717 [Abstract] [Full Text]  
• Hart, S. J., Davenport, M. L., Hooper, S. R., Belger, A. (2006). Visuospatial executive function in Turner syndrome: functional MRI and neurocognitive findings. Brain 129: 1125-1136 [Abstract] [Full Text]  
• Killian, J. K., Merino, M., Bondy, C., Bakalov, V., Chow, C. (2004). MRI of Angiolipoma of the Breast in Turner's Syndrome. Am. J. Roentgenol. 183: 1843-1844 [Full Text]  
• Molko, N., Cachia, A., Riviere, D., Mangin, J.F., Bruandet, M., LeBihan, D., Cohen, L., Dehaene, S. (2004). Brain Anatomy in Turner Syndrome: Evidence for Impaired Social and Spatial-Numerical Networks. Cereb Cortex 14: 840-850 [Abstract] [Full Text]  
• Frias, J. L., Davenport, M. L., Committee on Genetics, , Section on Endocrinology, (2003). Health Supervision for Children With Turner Syndrome. Pediatrics 111: 692-702 [Abstract] [Full Text]  
• Tazuke, S.I., Milki, A.A. (2002). Endometrioma of uterine serosa in a woman with mosaic Turner's syndrome receiving hormone replacement therapy: Case report. Hum Reprod 17: 2977-2980 [Abstract] [Full Text]  
• Gilchrist, D. M. (2002). Medical genetics: 3. An approach to the adult with a genetic disorder. CMAJ 167: 1021-1029 [Abstract] [Full Text]  
• Saenger, P., Wikland, K. A., Conway, G. S., Davenport, M., Gravholt, C. H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., Lippe, B., Pasquino, A. M., Ranke, M. B., Rosenfeld, R., Silberbach, M. (2001). Recommendations for the Diagnosis and Management of Turner Syndrome. J. Clin. Endocrinol. Metab. 86: 3061-3069 [Abstract] [Full Text]  
• Reiter, E. O., Blethen, S. L., Baptista, J., Price, L. (2001). Early Initiation of Growth Hormone Treatment Allows Age-Appropriate Estrogen Use in Turner's Syndrome. J. Clin. Endocrinol. Metab. 86: 1936-1941 [Abstract] [Full Text]  
• Orliaguet, O., Pepin, J.L., Bettega, G., Ferretti, G., Mignotte, H.N., Levy, P. (2001). Sleep apnoea and Turner's syndrome. Eur Respir J 17: 153-155 [Abstract] [Full Text]  
• Ibáñez, L., DiMartino-Nardi, J., Potau, N., Saenger, P. (2000). Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?. Endocr. Rev. 21: 671-696 [Abstract] [Full Text]  
• Efstathiadou, Z., Tsatsoulis, A. (2000). Turner's syndrome with concomitant hypopituitarism: Case report. Hum Reprod 15: 2388-2389 [Abstract] [Full Text]  
• (1999). Growth-Promoting Strategies in Turner's Syndrome. J. Clin. Endocrinol. Metab. 84: 4345-4348 [Full Text]  
• Querfeld, U., Döpper, S., Gradehand, A., Kiencke, P., Wahn, F., Zeisel, H.-J. (1999). Long-Term Treatment with Growth Hormone Has No Persisting Effect on Lipoprotein(a) in Patients with Turner's Syndrome. J. Clin. Endocrinol. Metab. 84: 967-970 [Abstract] [Full Text]  
• Gargan, T. J., Peerzada, J. M., Rozycki, A. A., Nordgren, R. E., Taback, S. P., Deal, C., Van Vliet, G., Saenger, P. (1997). Turner's Syndrome. NEJM 336: 1526-1528 [Full Text]